Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

190 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Completed

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

NCT03945318

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Amicis Research Center Northridge, California, United States
  • Colorado Kidney Care, P.C. Denver, Colorado, United States
  • Nephrology Associates of Central Florida Orlando, Florida, United States
  • Elixia Tampa, LLC Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study of Probiotics in IgA Nephropathy

NCT06767592

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Leicester General Hospital, University Hospitals of Leicester NHS Trust Leicester, Leicestershire, United Kingdom
View Trial Details
Completed

Exploring the Brain - Gut Microbiota - Kidney Interactive Damage Mechanisms Underlying Cognitive Decline in Patients With IgA Nephropathy Using Ultra-high Field Magnetic Resonance Imaging

NCT07617402

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Functional and Molecular Imaging Key Lab of Shaanxi Province, Department of Radiology, Tangdu Hospital, Fourth Military Medical University Shanxi, Xi'an, China
View Trial Details
Completed

Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease

NCT05083364

Conditions
Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +10 more
Locations
  • Research Site 1 Camperdown, New South Wales, Australia
  • Research Site 3 Concord, New South Wales, Australia
  • Research Site 2 Clayton, Victoria, Australia
  • Research Site 2 Tbilisi, Georgia
View all 16 locations
View Trial Details
Completed

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

NCT05065970

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • FOMAT Medical Research - FOMAT - HyperCore - PPDS Oxnard, California, United States
  • Amicis Research Center, Vacaville Vacaville, California, United States
  • Mayo Clinic Hospital - Methodist Campus Rochester, Minnesota, United States
  • MedResearch INC El Paso, Texas, United States
View all 59 locations
View Trial Details

Related conditions